Cargando…

Nomograms to predict overall survival and cancer-specific survival in patients with adrenocortical carcinoma

PURPOSE: To develop nomogram models to predict individualized estimates of overall survival (OS) and cancer-specific survival (CSS) in patients with adrenocortical carcinoma (ACC). PATIENTS AND METHODS: A total of 751 patients with ACC were identified within the Surveillance Epidemiology, and End Re...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yan, Bian, Xiaohui, Ouyang, Junyu, Wei, Shuyi, He, Meizhi, Luo, Zelong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300377/
https://www.ncbi.nlm.nih.gov/pubmed/30588100
http://dx.doi.org/10.2147/CMAR.S187169
_version_ 1783381668397056000
author Li, Yan
Bian, Xiaohui
Ouyang, Junyu
Wei, Shuyi
He, Meizhi
Luo, Zelong
author_facet Li, Yan
Bian, Xiaohui
Ouyang, Junyu
Wei, Shuyi
He, Meizhi
Luo, Zelong
author_sort Li, Yan
collection PubMed
description PURPOSE: To develop nomogram models to predict individualized estimates of overall survival (OS) and cancer-specific survival (CSS) in patients with adrenocortical carcinoma (ACC). PATIENTS AND METHODS: A total of 751 patients with ACC were identified within the Surveillance Epidemiology, and End Results (SEER) database between 1973 and 2015. The predictors comprised marital status, sex, age at diagnosis, year of diagnosis, laterality, histologic grade, ethnicity, historic stage, radiation therapy, chemotherapy, and surgery of primary site. Based on the results of the multivariate logistic regression analyses, the nomogram models were used for predicting OS and CSS in patients with ACC. The nomograms were tested using concordance index (C-index) and calibration curves. RESULTS: In univariate and multivariate analyses of OS, OS was significantly associated with age at diagnosis, year of diagnosis, histologic grade, historic stage, and chemotherapy. In univariate and multivariate analyses of CSS, age at diagnosis, year of diagnosis, historic stage, and chemotherapy were the independent risk factors with CSS. These characteristics were included in the nomograms predicting OS and CSS. The nomograms demonstrated good accuracy in predicting OS and CSS, with the C-index of 0.677 and 0.672. CONCLUSION: These clinically useful tools predicted OS and CSS in patients with ACC using readily available clinicopathologic factors and could aid individualized clinical decision making.
format Online
Article
Text
id pubmed-6300377
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-63003772018-12-26 Nomograms to predict overall survival and cancer-specific survival in patients with adrenocortical carcinoma Li, Yan Bian, Xiaohui Ouyang, Junyu Wei, Shuyi He, Meizhi Luo, Zelong Cancer Manag Res Original Research PURPOSE: To develop nomogram models to predict individualized estimates of overall survival (OS) and cancer-specific survival (CSS) in patients with adrenocortical carcinoma (ACC). PATIENTS AND METHODS: A total of 751 patients with ACC were identified within the Surveillance Epidemiology, and End Results (SEER) database between 1973 and 2015. The predictors comprised marital status, sex, age at diagnosis, year of diagnosis, laterality, histologic grade, ethnicity, historic stage, radiation therapy, chemotherapy, and surgery of primary site. Based on the results of the multivariate logistic regression analyses, the nomogram models were used for predicting OS and CSS in patients with ACC. The nomograms were tested using concordance index (C-index) and calibration curves. RESULTS: In univariate and multivariate analyses of OS, OS was significantly associated with age at diagnosis, year of diagnosis, histologic grade, historic stage, and chemotherapy. In univariate and multivariate analyses of CSS, age at diagnosis, year of diagnosis, historic stage, and chemotherapy were the independent risk factors with CSS. These characteristics were included in the nomograms predicting OS and CSS. The nomograms demonstrated good accuracy in predicting OS and CSS, with the C-index of 0.677 and 0.672. CONCLUSION: These clinically useful tools predicted OS and CSS in patients with ACC using readily available clinicopathologic factors and could aid individualized clinical decision making. Dove Medical Press 2018-12-13 /pmc/articles/PMC6300377/ /pubmed/30588100 http://dx.doi.org/10.2147/CMAR.S187169 Text en © 2018 Li et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Li, Yan
Bian, Xiaohui
Ouyang, Junyu
Wei, Shuyi
He, Meizhi
Luo, Zelong
Nomograms to predict overall survival and cancer-specific survival in patients with adrenocortical carcinoma
title Nomograms to predict overall survival and cancer-specific survival in patients with adrenocortical carcinoma
title_full Nomograms to predict overall survival and cancer-specific survival in patients with adrenocortical carcinoma
title_fullStr Nomograms to predict overall survival and cancer-specific survival in patients with adrenocortical carcinoma
title_full_unstemmed Nomograms to predict overall survival and cancer-specific survival in patients with adrenocortical carcinoma
title_short Nomograms to predict overall survival and cancer-specific survival in patients with adrenocortical carcinoma
title_sort nomograms to predict overall survival and cancer-specific survival in patients with adrenocortical carcinoma
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300377/
https://www.ncbi.nlm.nih.gov/pubmed/30588100
http://dx.doi.org/10.2147/CMAR.S187169
work_keys_str_mv AT liyan nomogramstopredictoverallsurvivalandcancerspecificsurvivalinpatientswithadrenocorticalcarcinoma
AT bianxiaohui nomogramstopredictoverallsurvivalandcancerspecificsurvivalinpatientswithadrenocorticalcarcinoma
AT ouyangjunyu nomogramstopredictoverallsurvivalandcancerspecificsurvivalinpatientswithadrenocorticalcarcinoma
AT weishuyi nomogramstopredictoverallsurvivalandcancerspecificsurvivalinpatientswithadrenocorticalcarcinoma
AT hemeizhi nomogramstopredictoverallsurvivalandcancerspecificsurvivalinpatientswithadrenocorticalcarcinoma
AT luozelong nomogramstopredictoverallsurvivalandcancerspecificsurvivalinpatientswithadrenocorticalcarcinoma